Home Reports Life Sciences Content

Biacore launches new generation system for protein interaction analysis

next article

17.02.2005

Unmatched performance of Biacore T100 supports critical decision-making from research through to manufacturing and QC

Uppsala, Sweden, February 7, 2005. Biacore International AB (Biacore) (SSE: BCOR) today announced the launch of Biacore T100, a new generation system for protein interaction analysis.

Biacore T100 provides comprehensive information about how proteins interact with other molecules. The unique information generated by Biacore T100 is invaluable for many applications such as elucidation of disease pathways, definition of therapeutic targets, selection of drug candidates and decisions on the safety of a protein therapeutic.

Biacore T100 sets the performance standard for protein interaction analysis, from research through drug discovery and development to manufacturing and QC, providing the highest quality data to support decisions that ensure productive research and development. From a single instrument, scientists can determine affinity and rate constants, binding specificity, concentration and thermodynamic parameters. In this way, applications as time-consuming as antibody characterization, which could take weeks by conventional methods, can be completed in days with Biacore T100. Software wizards assist with the analysis of every interaction parameter, making the system straightforward to use and suitable for both novice and experienced users.

Initially acknowledged as essential in basic research, the unique data provided by Biacore systems are now widely used by biotechnology and pharmaceutical companies to make well-informed decisions at critical stages throughout the development and manufacture of novel therapeutics. To fulfill stringent regulatory requirements, Biacore T100 has been designed with a high level of in-built GLP/GMP/GCP support and 21 CFR Part 11 compliance. An optional GxP support package will save users significant time during validation.

Erik Walldén, Biacore’s President and CEO commented:

“Biacore T100 is our new flagship system, the fruit of our skills and expertise gained through 15 years of experience since we introduced real time protein interaction analysis into the life science market. We are confident that both existing and new Biacore users will benefit from the system’s unmatched performance and ease-of-use. Biacore T100 offers even greater opportunities for scientists to benefit from real time protein interaction analysis wherever they work in the life sciences.“

Rowan Minnion | Source: alphagalileo
Further information: www.biacore.com
www.northbankcommunications.com

next article